PTCT
PTC Therapeutics Inc
Price:  
37.20 
USD
Volume:  
540,526.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT WACC - Weighted Average Cost of Capital

The WACC of PTC Therapeutics Inc (PTCT) is 7.6%.

The Cost of Equity of PTC Therapeutics Inc (PTCT) is 9.40%.
The Cost of Debt of PTC Therapeutics Inc (PTCT) is 5.50%.

Range Selected
Cost of equity 7.70% - 11.10% 9.40%
Tax rate 4.90% - 6.40% 5.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.0% - 9.1% 7.6%
WACC

PTCT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.83 1.1
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 11.10%
Tax rate 4.90% 6.40%
Debt/Equity ratio 0.74 0.74
Cost of debt 4.00% 7.00%
After-tax WACC 6.0% 9.1%
Selected WACC 7.6%